Annual Total Assets
$8.09 M
+$4.03 M+99.26%
31 December 2023
Summary:
Titan Pharmaceuticals annual total assets is currently $8.09 million, with the most recent change of +$4.03 million (+99.26%) on 31 December 2023. During the last 3 years, it has fallen by -$1000.00 (-0.01%). TTNP annual total assets is now -93.17% below its all-time high of $118.44 million, reached on 31 December 2000.TTNP Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$4.35 M
-$2.30 M-34.55%
30 June 2024
Summary:
Titan Pharmaceuticals quarterly total assets is currently $4.35 million, with the most recent change of -$2.30 million (-34.55%) on 30 June 2024. Over the past year, it has dropped by -$5.65 million (-56.50%). TTNP quarterly total assets is now -96.33% below its all-time high of $118.44 million, reached on 31 December 2000.TTNP Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTNP Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +99.3% | -56.5% |
| 3 y3 years | -0.0% | -54.9% |
| 5 y5 years | -42.6% | -18.0% |
TTNP Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.0% | +99.3% | -57.8% | +435.7% |
| 5 y | 5 years | -42.6% | +99.3% | -68.5% | +435.7% |
| alltime | all time | -93.2% | +117.0% | -96.3% | +435.7% |
Titan Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | $4.35 M(-34.5%) |
| Mar 2024 | - | $6.65 M(-17.8%) |
| Dec 2023 | $8.09 M(+99.3%) | $8.09 M(-19.1%) |
| Sept 2023 | - | $10.00 M(+1131.4%) |
| June 2023 | - | $812.00 K(-62.5%) |
| Mar 2023 | - | $2.17 M(-46.6%) |
| Dec 2022 | $4.06 M(-49.2%) | $4.06 M(-35.3%) |
| Sept 2022 | - | $6.28 M(-24.6%) |
| June 2022 | - | $8.32 M(-19.4%) |
| Mar 2022 | - | $10.32 M(+29.1%) |
| Dec 2021 | $7.99 M(-1.1%) | $7.99 M(-17.0%) |
| Sept 2021 | - | $9.64 M(-16.3%) |
| June 2021 | - | $11.51 M(-16.8%) |
| Mar 2021 | - | $13.82 M(+70.9%) |
| Dec 2020 | $8.09 M(-15.1%) | $8.09 M(+0.9%) |
| Sept 2020 | - | $8.02 M(-17.9%) |
| June 2020 | - | $9.76 M(-26.4%) |
| Mar 2020 | - | $13.26 M(+39.3%) |
| Dec 2019 | $9.52 M(-32.4%) | $9.52 M(+79.5%) |
| Sept 2019 | - | $5.30 M(-21.6%) |
| June 2019 | - | $6.76 M(-40.9%) |
| Mar 2019 | - | $11.44 M(-18.8%) |
| Dec 2018 | $14.10 M(+58.3%) | $14.10 M(+18.9%) |
| Sept 2018 | - | $11.85 M(+156.7%) |
| June 2018 | - | $4.62 M(-12.7%) |
| Mar 2018 | - | $5.29 M(-40.6%) |
| Dec 2017 | $8.90 M(-52.3%) | $8.90 M(-30.1%) |
| Sept 2017 | - | $12.74 M(+35.3%) |
| June 2017 | - | $9.41 M(-28.0%) |
| Mar 2017 | - | $13.07 M(-30.0%) |
| Dec 2016 | $18.67 M(+40.5%) | $18.67 M(-20.7%) |
| Sept 2016 | - | $23.54 M(-7.0%) |
| June 2016 | - | $25.30 M(+110.9%) |
| Mar 2016 | - | $12.00 M(-9.7%) |
| Dec 2015 | $13.29 M(-36.3%) | $13.29 M(-10.9%) |
| Sept 2015 | - | $14.91 M(-13.9%) |
| June 2015 | - | $17.31 M(-5.8%) |
| Mar 2015 | - | $18.39 M(-11.8%) |
| Dec 2014 | $20.85 M(+13.2%) | $20.85 M(+57.8%) |
| Sept 2014 | - | $13.22 M(-7.2%) |
| June 2014 | - | $14.25 M(-11.6%) |
| Mar 2014 | - | $16.12 M(-12.5%) |
| Dec 2013 | $18.42 M(-25.8%) | $18.42 M(+18.7%) |
| Sept 2013 | - | $15.52 M(-8.2%) |
| June 2013 | - | $16.91 M(-28.1%) |
| Mar 2013 | - | $23.53 M(-5.2%) |
| Dec 2012 | $24.83 M(+143.0%) | $24.83 M(+131.1%) |
| Sept 2012 | - | $10.74 M(+6.9%) |
| June 2012 | - | $10.05 M(+33.9%) |
| Mar 2012 | - | $7.51 M(-26.5%) |
| Dec 2011 | $10.22 M(+115.0%) | $10.22 M(+56.0%) |
| Sept 2011 | - | $6.55 M(-25.9%) |
| June 2011 | - | $8.84 M(+174.7%) |
| Mar 2011 | - | $3.22 M(-32.3%) |
| Dec 2010 | $4.75 M | $4.75 M(-44.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2010 | - | $8.55 M(+309.7%) |
| June 2010 | - | $2.09 M(-72.0%) |
| Mar 2010 | - | $7.45 M(+99.9%) |
| Dec 2009 | $3.73 M(-87.9%) | $3.73 M(-72.4%) |
| Sept 2008 | - | $13.50 M(-30.7%) |
| June 2008 | - | $19.47 M(-24.4%) |
| Mar 2008 | - | $25.74 M(-16.6%) |
| Dec 2007 | $30.84 M(+105.1%) | $30.84 M(+114.3%) |
| Sept 2007 | - | $14.39 M(-22.9%) |
| June 2007 | - | $18.68 M(+58.4%) |
| Mar 2007 | - | $11.79 M(-21.6%) |
| Dec 2006 | $15.04 M(-23.8%) | $15.04 M(-19.8%) |
| Sept 2006 | - | $18.75 M(-13.6%) |
| June 2006 | - | $21.70 M(-13.8%) |
| Mar 2006 | - | $25.15 M(+27.4%) |
| Dec 2005 | $19.74 M(-48.9%) | $19.74 M(-6.9%) |
| Sept 2005 | - | $21.20 M(-20.0%) |
| June 2005 | - | $26.50 M(-20.0%) |
| Mar 2005 | - | $33.14 M(-14.2%) |
| Dec 2004 | $38.63 M(-21.2%) | $38.63 M(-15.3%) |
| Sept 2004 | - | $45.58 M(-10.5%) |
| June 2004 | - | $50.93 M(-12.4%) |
| Mar 2004 | - | $58.14 M(+18.6%) |
| Dec 2003 | $49.01 M(-35.5%) | $49.01 M(-13.0%) |
| Sept 2003 | - | $56.32 M(-10.2%) |
| June 2003 | - | $62.73 M(-9.5%) |
| Mar 2003 | - | $69.29 M(-8.7%) |
| Dec 2002 | $75.93 M(-29.1%) | $75.93 M(-9.7%) |
| Sept 2002 | - | $84.04 M(-8.6%) |
| June 2002 | - | $91.92 M(-7.0%) |
| Mar 2002 | - | $98.88 M(-7.7%) |
| Dec 2001 | $107.13 M(-9.5%) | $107.13 M(-3.0%) |
| Sept 2001 | - | $110.49 M(-3.5%) |
| June 2001 | - | $114.47 M(-1.2%) |
| Mar 2001 | - | $115.87 M(-2.2%) |
| Dec 2000 | $118.44 M(+149.9%) | $118.44 M(+46.9%) |
| Sept 2000 | - | $80.63 M(-3.5%) |
| June 2000 | - | $83.51 M(-2.7%) |
| Mar 2000 | - | $85.80 M(+81.0%) |
| Dec 1999 | $47.40 M(+288.5%) | $47.40 M(+388.7%) |
| Sept 1999 | - | $9.70 M(-21.8%) |
| June 1999 | - | $12.40 M(-19.5%) |
| Mar 1999 | - | $15.40 M(+26.2%) |
| Dec 1998 | $12.20 M(-52.3%) | $12.20 M(-18.7%) |
| Sept 1998 | - | $15.00 M(-15.3%) |
| June 1998 | - | $17.70 M(-11.5%) |
| Mar 1998 | - | $20.00 M(-21.9%) |
| Dec 1997 | $25.60 M(+56.1%) | $25.60 M(+224.1%) |
| Sept 1997 | - | $7.90 M(-42.8%) |
| June 1997 | - | $13.80 M(+30.2%) |
| Mar 1997 | - | $10.60 M(-35.4%) |
| Dec 1996 | $16.40 M(+248.9%) | $16.40 M(-16.8%) |
| Sept 1996 | - | $19.70 M(+123.9%) |
| June 1996 | - | $8.80 M(-25.4%) |
| Mar 1996 | - | $11.80 M(+151.1%) |
| Dec 1995 | $4.70 M | $4.70 M |
FAQ
- What is Titan Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals annual total assets year-on-year change?
- What is Titan Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Titan Pharmaceuticals?
- What is Titan Pharmaceuticals quarterly total assets year-on-year change?
What is Titan Pharmaceuticals annual total assets?
The current annual total assets of TTNP is $8.09 M
What is the all time high annual total assets for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high annual total assets is $118.44 M
What is Titan Pharmaceuticals annual total assets year-on-year change?
Over the past year, TTNP annual total assets has changed by +$4.03 M (+99.26%)
What is Titan Pharmaceuticals quarterly total assets?
The current quarterly total assets of TTNP is $4.35 M
What is the all time high quarterly total assets for Titan Pharmaceuticals?
Titan Pharmaceuticals all-time high quarterly total assets is $118.44 M
What is Titan Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, TTNP quarterly total assets has changed by -$5.65 M (-56.50%)